Concepedia

1040O Phase II trial of ipilimumab, nivolumab and tocilizumab for unresectable metastatic melanoma

Jeffrey S. Weber, Takashi Muramatsu, Omid Hamid, J. Mehnert, F. Stephen Hodi, Swathi Krishnarajapet, Saundra Malatyali, Elizabeth I. Buchbinder, Judith D. Goldberg, Ryan J. Sullivan,

Annals of Oncology · 2021 · 25 citations · 0 references

Open access

Concepts

MedicineClinical SciencesOncologyImmunotherapyMetastasisTumor ImmunologyCancer ImmunotherapyCheckpoint Inhibitor TherapyCombination ImmunotherapyMelanocytic TumorsMelanoma PharmacotherapyMetastatic Disease TreatmentMelanoma ImmunotherapyMelanoma ProgressionMetastatic Melanoma TreatmentPhase Ii Investigation